Albuquerque, NM – 2 July 2024 – Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region.
Albuquerque, NM – 23 May 2024 – Indica Labs, the global leader in AI-powered digital pathology solutions, announced today the release of the transformative new version of its industry-leading life sciences software.
27 June 2024 | Join us for this 1-hour webinar to see a live demonstration of the HALO® image analysis platform focused on Indica Labs’ pretrained and untrained AI nuclear and membrane segmentation models.
25 June 2024 | Join us for this 1-hour webinar to see a live demonstration of the HALO® image analysis platform focused on highly multiplexed immunofluorescence slides.
30 May 2024 | Histologic evaluation of the mucosal changes associated with celiac disease is important for establishing an accurate diagnosis and monitoring the impact of investigational therapies.
Pathologist-Trained Machine Learning Classifiers Quantitate Celiac Disease Features Read More »
Albuquerque, NM, and Los Angeles, CA – 5 April 2024 – Indica Labs, a leading provider of AI-powered digital pathology solutions, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging technology, announce a new partnership to co-market compatibility between MI’s patented HCR™ Imaging technology and Indica’s HALO® software.
16 May 2024 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 16 from 1 pm – 5 pm. A lunch will be provided to all pre-registered attendees at 12 pm.
Indica Labs’ Boston HALO® User Group Meeting Read More »
6 June 2024 | Join us for this 1-hour webinar to see a live demonstration of the new versions of the industry leading AI-powered HALO® and HALO AI digital pathology image analysis platform and the HALO Link collaborative image management platform.
AI-Powered Pathology with HALO®, HALO AI, and HALO Link 4.0 Read More »
18 April 2024 | In this 1-hour webinar learn about SlideQC BF 3.0, an AI-based image quality control network that detects and segments most common artifacts including air bubbles, debris, folds, out of focus regions, and pen marker in both hematoxylin and eosin (H&E) and immunohistochemistry (IHC) images.
AI-based Slide Quality Control Workflows for Life Science and Clinical Applications Read More »
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist of AI Collaborations at Indica Labs, will present case studies of customer collaborations resulting in the development and validation of commercially available and inter-operable AI algorithms addressing customer needs.
